Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
BJC Reports|September 2, 2024
Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancerAnthony Kong, Amanda J Kirkham, Joshua S Savage, et al.
BMJ Open Respiratory Research|March 27, 2026
Comparison of tissue acquisition techniques for Next-Generation Sequencing of non-small cell lung cancer (NSCLC)Amyn Bhamani, Sindhu Bhaarrati Naidu, Naimish Adroja, et al.
Future Oncology (London, England)|April 14, 2021
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumorsMartina Puglisi, L Rhoda Molife, Maja Ja de Jonge, et al.
Investigational New Drugs|March 12, 2017
Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancersJennifer R Diamond, Barbara Goff, Martin D Forster, et al.
Critical Reviews in Oncology/Hematology|April 28, 2025
Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challengesPablo Jiménez-Labaig, Luigi Lorini, Cristina Gurizzan, et al.
The Oncologist|June 1, 2023
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung CancerMelinda A Pruis, Matthew G Krebs, Ruth Plummer, et al.
Cancers|March 28, 2024
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid TumorsFilip Janku, Grace M Choong, Mateusz Opyrchal, et al.
BMJ Open Respiratory Research|June 9, 2026
Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocolSindhu Bhaarrati Naidu, Gabrielle Guvensen, Honghan Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaJeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
Dendrimer-nanoparticle (DEP) delivery of cabazitaxel (DEP-cabazitaxel): A first-in-human phase 1/2 trial in patients with advanced solid tumoursRobert H Jones, David J Pinato, Martin D Forster, et al.
Pageof 6